270 related articles for article (PubMed ID: 16215614)
21. Understanding the genetic determinants of pain and pain management.
Miaskowski C
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
[TBL] [Abstract][Full Text] [Related]
22. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
23. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
24. Human Genetic Variability Contributes to Postoperative Morphine Consumption.
De Gregori M; Diatchenko L; Ingelmo PM; Napolioni V; Klepstad P; Belfer I; Molinaro V; Garbin G; Ranzani GN; Alberio G; Normanno M; Lovisari F; Somaini M; Govoni S; Mura E; Bugada D; Niebel T; Zorzetto M; De Gregori S; Molinaro M; Fanelli G; Allegri M
J Pain; 2016 May; 17(5):628-36. PubMed ID: 26902643
[TBL] [Abstract][Full Text] [Related]
25. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia.
Sia AT; Lim Y; Lim EC; Goh RW; Law HY; Landau R; Teo YY; Tan EC
Anesthesiology; 2008 Sep; 109(3):520-6. PubMed ID: 18719451
[TBL] [Abstract][Full Text] [Related]
26. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
27. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
Hayashida M; Maruyama K
Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
[TBL] [Abstract][Full Text] [Related]
28. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population.
Lloret Linares C; Hajj A; Poitou C; Simoneau G; Clement K; Laplanche JL; Lépine JP; Bergmann JF; Mouly S; Peoc'h K
Obes Surg; 2011 Aug; 21(8):1257-64. PubMed ID: 20411349
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
[TBL] [Abstract][Full Text] [Related]
30. Current evidence for a genetic modulation of the response to analgesics.
Lötsch J; Geisslinger G
Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
[No Abstract] [Full Text] [Related]
31. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics and Morphine.
Ofoegbu A; B Ettienne E
J Clin Pharmacol; 2021 Sep; 61(9):1149-1155. PubMed ID: 33847389
[TBL] [Abstract][Full Text] [Related]
33. Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains.
Shigeta Y; Kasai S; Han W; Hata H; Nishi A; Takamatsu Y; Hagino Y; Yamamoto H; Koide T; Shiroishi T; Kasai K; Tsunashima K; Kato N; Ikeda K
Pharmacogenet Genomics; 2008 Nov; 18(11):927-36. PubMed ID: 18854775
[TBL] [Abstract][Full Text] [Related]
34. Genetics and variability in opioid response.
Stamer UM; Bayerer B; Stüber F
Eur J Pain; 2005 Apr; 9(2):101-4. PubMed ID: 15737794
[TBL] [Abstract][Full Text] [Related]
35. [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?].
Fukuda K; Hayashida M; Ikeda K
Masui; 2009 Sep; 58(9):1102-8. PubMed ID: 19764432
[TBL] [Abstract][Full Text] [Related]
36. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between Oprm1 polymorphism and morphine sensitivity in inbred-strain mice derived from wild mice].
Kasai S; Kan F; Hata H; Takamatsu Y; Hagino Y; Shiroishi T; Koide T; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Apr; 31(2):87-88. PubMed ID: 21870367
[No Abstract] [Full Text] [Related]
38. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
39. [Individual differences in analgesic effects of narcotics].
Ide S; Kasai S; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
[TBL] [Abstract][Full Text] [Related]
40. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.
Chou WY; Yang LC; Lu HF; Ko JY; Wang CH; Lin SH; Lee TH; Concejero A; Hsu CJ
Acta Anaesthesiol Scand; 2006 Aug; 50(7):787-92. PubMed ID: 16879459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
